MedPath

Studies on the frequency of PDL-1 positive peripheral mononuclear cells and blood level of soluble PDL-1 in pancreatic cancer patients treated with dendritic cell therapy

Not Applicable
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000029377
Lead Sponsor
Jikei University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Pancreatic cancer patients not applicable to the dendritic cell therapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath